鼻咽癌个体化血管生成与 TIL(肿瘤浸润淋巴细胞)预后特征的建立与验证
Development and validation of an individualized angiogenesis and tumor-infiltrating lymphocytes prognostic signature in nasopharyngeal carcinoma.
CO V+TIL 评分高的鼻咽癌患者预后更差。
32.0分
★☆☆☆☆
DISEASE HUB
FOR TREATMENT
按「中国试验优先 → 正在招募 → 更新更近」排序。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Development and validation of an individualized angiogenesis and tumor-infiltrating lymphocytes prognostic signature in nasopharyngeal carcinoma.
CO V+TIL 评分高的鼻咽癌患者预后更差。
MEMBER ACCOUNT
登录成功会直接打开下一页。